Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Deep Vein ◽

Adjusted Dose

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

Journal of Vascular Surgery ◽

10.1016/0741-5214(93)90354-o ◽

1993 ◽

Vol 18 (5) ◽

pp. 899-900

Author(s):

Jean-Baptiste Ricco

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery

Journal of Vascular Surgery ◽

10.1016/0741-5214(87)90025-5 ◽

1987 ◽

Vol 6 (4) ◽

pp. 427-428

Author(s):

Anthony D. Whittemore

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Controlled Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Evidence-Based Evaluation of Preoperative vs Postoperative Use of Low-Molecular-Weight Heparin in Preventing Deep Vein Thrombosis in Elective Hip Surgery

Archives of Internal Medicine ◽

10.1001/archinte.159.14.1622 ◽

1999 ◽

Vol 159 (14) ◽

pp. 1622-1623

Author(s):

A. Ghosh

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Hip Surgery ◽

Low Molecular Weight ◽

Evidence Based ◽

Vein Thrombosis ◽

Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

British Journal of Haematology ◽

10.1046/j.1365-2141.1999.01153.x ◽

1999 ◽

Vol 104 (2) ◽

pp. 230-240 ◽

Cited By ~ 64

Author(s):

Lucienne Bara ◽

André Planes ◽

Meyer-Michel Samama

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Plasma Levels ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Deep Vein ◽

D Dimer

A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery

New England Journal of Medicine ◽

10.1056/nejm198610093151503 ◽

1986 ◽

Vol 315 (15) ◽

pp. 925-929 ◽

Cited By ~ 353

Author(s):

Alexander G.G. Turpie ◽

Mark N. Levine ◽

Jack Hirsh ◽

Cedric J. Carter ◽

Richard M. Jay ◽

...

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Controlled Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

A Randomized Controlled Trial of Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery

Survey of Anesthesiology ◽

10.1097/00132586-198708000-00034 ◽

1987 ◽

Vol XXXI (4) ◽

pp. 225

Author(s):

A. G. G. TURPIE ◽

M. N. LEVINE ◽

J. HIRSH ◽

C. J. CARTER ◽

R. M. JAY ◽

...

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Controlled Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Ximelagatran versus low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial

Obstetrics and Gynecology ◽

10.1097/01.aog.0000162923.87623.78 ◽

2005 ◽

Vol 105 (5, Part 1) ◽

pp. 1146

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Randomized Trial ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Comparison of the Use of a Foot Pump with the Use of Low-Molecular-Weight Heparin for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement. A Prospective, Randomized Trial*

The Journal of Bone and Joint Surgery (American) ◽

10.2106/00004623-199808000-00009 ◽

1998 ◽

Vol 80 (8) ◽

pp. 1158-66 ◽

Cited By ~ 123

Author(s):

DAVID WARWICK ◽

JEFFREY HARRISON ◽

DAVID GLEW ◽

ANDREW MITCHELMORE ◽

TIM J. PETERS ◽

...

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Randomized Trial ◽

Total Hip Replacement ◽

Hip Replacement ◽

Prospective Randomized Trial ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Faculty Opinions recommendation of Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1124847.581938 ◽

2008 ◽

Author(s):

Mark Hamilton ◽

Marcus Peck

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Renal Insufficiency ◽

Critically Ill ◽

Critically Ill Patients ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Severe Renal Insufficiency ◽

Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis

Medicina Clínica ◽

10.1016/j.medcli.2021.01.012 ◽

2021 ◽

Author(s):

Pedro M. García-Ceberino ◽

Naya Faro-Míguez ◽

Francisco Javier Beltrán-Ávila ◽

Daniel Fernández-Reyes ◽

Inmaculada Gallardo-Muñoz ◽

...

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Point Of Care ◽

High Rate ◽

Low Molecular Weight ◽

Point Of Care Ultrasound ◽

Vein Thrombosis ◽

Deep Vein ◽

Heparin Prophylaxis